SDTM IG - Trial Design - Eligibility, Summary, and Reverse Review Question 1 of 23
Reverse-flow: A TA dataset has two broad arms, while TS for Phase 3 says INTMODEL = PARALLEL, NARMS = 2, RANDOM = Y, and the objective compares combination therapy versus monotherapy. What should the reviewer expect?